WHO ICTRP trial
A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the…
EUCTR2008-000639-16-CZ · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-000639-16-CZ |
|---|---|
| Public title | A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective Tinnitus |
| Scientific title | A Randomized, Double-Blind, Placebo-Controlled, Clinical Evaluation of the Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective Tinnitus |
| Primary sponsor | Merz Pharmaceuticals GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Czech Republic;Netherlands;France |
| Conditions | Efficacy, Safety and Tolerability of Neramexane in Patients with Subjective Tinnitus MedDRA version: 9.1 Level: LLT Classification code 10042398 Term: Subjective tinnitus |
| Interventions | Product Name: Neramexane mesylate IR film-coated tablet 12.5 mg Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Neramexane Mesylate CAS Number: 457068-92-7 Other descriptive name: 1-amino-1,3,3,5,5-pentamethylcyclohexane… |
| Registration date | Jul 25, 2008 |
| Target size | 400 |
| Secondary IDs | MRZ 92579-TI/3002 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: